Creative Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers.
AI & Machine LearningDigital HealthHealthtechMedical DevicesToronto, CA
Ahmed El Kaffas(Founder)Beth Rogozinski(CEO)in
Co-investorsPallasite VenturesSaltagen VenturesSony Ventures CorporationUCeed Funds
Circuit Mind develops a platform that converts hardware architecture into verified schematics and bills of materials using algorithms and software for electronics engineers and design teams.
Advanced ManufacturingAI & Machine LearningDeveloper ToolsHardwareLondon, GB
EdTomide Adesanmi(CEO)inBasilio Gentile(CTO)in
Co-investors7percent VenturesBlackhorn VenturesDifferential VenturesEntrepreneur FirstEpisode1GRIDS Capital+7 more
OncoPrecision develops precision oncology medicines, including antibody-drug conjugates and bispecific antibodies, for blood cancers and hard-to-treat solid tumors.
AI & Machine LearningBiotechMedical Devices
Gastón Soria(Co-Founder & CSO)in
Co-investorsAIR CapitalGRIDXSOSV
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















